Pharma Marketing Network

AUGUST 9, 2023

It’s crucial for marketing teams to stay informed about the latest guidelines, policies, and updates from regulatory bodies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in the European Union.

Marketing 52

Marketing Pharma Food and Drug Administration Media 52

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.

Patients 59

Patients Pharma Education Media 59

Pharma Marketing Network

AUGUST 9, 2023

It’s crucial for marketing teams to stay informed about the latest guidelines, policies, and updates from regulatory bodies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in the European Union.

Marketing 40

Marketing Pharma Food and Drug Administration Media 40

pharmaphorum

NOVEMBER 16, 2022

Having presented the data from the 24-month phase 3 trial at the American Academy of Ophthalmology (AAO) annual meeting, Dr Wykoff set aside some time to go into further detail with pharmaphorum about how the results were received, and what glimmer of hope this might hold for patients with GA. Working against the odds. “As

Safety 96

Safety Patients Consulting Prospecting 96

Clarivate

JUNE 21, 2023

Under the AI Act, medical or in vitro diagnostic medical devices that are AI-powered or incorporate AI as a safety component come under both the MDR/IVDR and the AI Act. Medtech developers will need to obtain relevant certificates to show that their AI technologies meet the required standards of safety, accuracy, reliability, and ethics.

Medical 52

Medical Safety Ethics Healthcare 52

Nixon Gwilt Law

NOVEMBER 28, 2023

Healthcare innovators and digital health developers are constantly on the lookout for groundbreaking technologies to revolutionize patient care. Personalized patient education: Developing systems that generate personalized educational content for patients based on their medical history, condition, and treatment plans.

Healthcare 52

Healthcare Healthcare Medical Education 52

MedReps

SEPTEMBER 19, 2022

Another enduring wall for medical sales reps to climb is making their products affordable to patients. Yes, all physicians take an oath to best treat their patients, but that doesn’t mean they’re going to think your product is worth the effort. Insurance Coverage. Physician Apathy. Competitors and Generic Medications.

Medical sales 66

Medical sales Medical sales reps Medical Sales 66

Clarivate

MARCH 17, 2022

How feasible is it to establish a drug’s safety for use in a population that may be unwilling or unable to participate in clinical trials? Experts at a November 2021 Food and Drug Administration (FDA) meeting also wrestled with this theme of clinical trials and pregnancy. Medicine use during pregnancy: balancing risks.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

pharmaphorum

NOVEMBER 3, 2022

Food and Drug Administration’s (FDA) draft guidance, “ Digital Health Technologies for Remote Data Acquisition in Clinical Investigations ”. We see how digital measures of adherence ensure that sample size calculations hold and drug developers can accurately evaluate the safety and efficacy of new molecules.

Pharma 80

Pharma Medicine Education Recruitment 80

Pharmaceutical Technology

DECEMBER 21, 2022

This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. In pharmaceutical research, this may help secure the privacy of patient data used by AI systems and decrease bias due to ethnicity, sex and other factors. FDA and EMA action.

Pharma 140

Pharma Medicine Pharmaceutical Government 140

pharmaphorum

AUGUST 19, 2022

Since DiMe’s launch in October 2019, there has been a 929% increase in the number of digital endpoints being used by the life sciences industry for the safety and efficacy of new drug development. DiMe is ready to help get data out of the cloud and into the hands of those who need it to improve patients’ lives.

Medicine 52

Medicine Healthcare Healthcare Ethics 52

Clarify Health

DECEMBER 13, 2022

Less than four percent of Americans participate in clinical studies; 30 percent of patients drop out; and 80 percent of studies do not meet enrollment deadlines. Dr. Rizk provided an example of how we’re getting better at meeting patients where they are. Below are highlights and key takeaways from the panel.

Recruitment 52

Recruitment Retail Patients Education 52

Clarify Health

DECEMBER 13, 2022

Less than four percent of Americans participate in clinical studies; 30 percent of patients drop out; and 80 percent of studies do not meet enrollment deadlines. Dr. Rizk provided an example of how we’re getting better at meeting patients where they are. Below are highlights and key takeaways from the panel.

Recruitment 52

Recruitment Retail Patients Education 52

Pharmaceutical Technology

MARCH 16, 2023

However, health specialists refute most safety concerns for the use of drug classes as part of gender affirming care, citing years of research and care. Dr. Barry DeCoster, PhD, an associate professor of bioethics at the University of Michigan, describes gender affirming care as “safe and effective” for most patients.

Ethics 144

Ethics Prescription Safety Healthcare 144